Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer?
Open Access
- 28 February 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (5), 2399
- https://doi.org/10.3390/ijerph18052399
Abstract
Lung cancer still represents the leading cause of cancer-related death, globally. Likewise, malnutrition and inactivity represent a major risk for loss of functional pulmonary capacities influencing overall lung cancer severity. Therefore, the adhesion to an appropriate health lifestyle is crucial in the management of lung cancer patients despite the subtype of cancer. This review aims to summarize the available knowledge about dietary approaches as well as physical activity as the major factors that decrease the risk towards lung cancer, and improve the response to therapies. We discuss the most significant dietary schemes positively associated to body composition and prognosis of lung cancer and the main molecular processes regulated by specific diet schemes, functional foods and physical activity, i.e., inflammation and oxidative stress. Finally, we report evidence demonstrating that dysbiosis of lung and/or gut microbiome, as well as their interconnection (the gut–lung axis), are strictly related to dietary patterns and regular physical activity playing a key role in lung cancer formation and progression, opening to the avenue of modulating the microbiome as coadjuvant therapy. Altogether, the evidence reported in this review highlights the necessity to consider non-pharmacological interventions (nutrition and physical activity) as effective adjunctive strategies in the management of lung cancer.This publication has 181 references indexed in Scilit:
- Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdownAnnals of the New York Academy of Sciences, 2012
- Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse ModelPLOS ONE, 2012
- Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot studySupportive Care in Cancer, 2012
- Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCTEuropean Journal of Clinical Nutrition, 2012
- Physiopathological Mechanism of SarcopeniaClinics in Geriatric Medicine, 2011
- Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapyCancer, 2011
- Malnutrition: causes and consequencesClinical Medicine, 2010
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer PatientsCancer Research, 2010
- Interleukin-6 and cachexia inApcMin/+miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Leisure-time physical activity and lung cancer: a meta-analysisCancer Causes & Control, 2005